Global Patient Derived Xenograft and PDX Models Market Research Report 2024(Status and Outlook)
Report Overview:
Patient derived xenografts (PDX) are models of cancer where the tissue or cells from a patient's tumor are implanted into an immunodeficient or humanized mouse. PDX models are used to create an environment that allows for the natural growth of cancer, its monitoring, and corresponding treatment evaluations for the original patient.
The Global Patient Derived Xenograft and PDX Models Market Size was estimated at USD 364.79 million in 2023 and is projected to reach USD 595.15 million by 2029, exhibiting a CAGR of 8.50% during the forecast period.
This report provides a deep insight into the global Patient Derived Xenograft and PDX Models market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Patient Derived Xenograft and PDX Models Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Patient Derived Xenograft and PDX Models market in any manner.
Global Patient Derived Xenograft and PDX Models Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Crown Bioscience
The Jackson Laboratory
Champions Oncology
Charles River Laboratories
WuXi Apptec
Oncodesign
Horizon Discovery
Pharmatest Services
Hera Biolabs
EPO Berlin-Buch
Xentech
Urolead
Market Segmentation (by Type)
Mice Models
Rat Models
Market Segmentation (by Application)
Pre-clinical Drug Development and Basic Cancer Research
Biomarker Analysis
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Patient Derived Xenograft and PDX Models Market
Overview of the regional outlook of the Patient Derived Xenograft and PDX Models Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Patient Derived Xenograft and PDX Models Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Patient Derived Xenograft and PDX Models
- 1.2 Key Market Segments
- 1.2.1 Patient Derived Xenograft and PDX Models Segment by Type
- 1.2.2 Patient Derived Xenograft and PDX Models Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Patient Derived Xenograft and PDX Models Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Patient Derived Xenograft and PDX Models Market Size (M USD) Estimates and Forecasts (2019-2030)
- 2.1.2 Global Patient Derived Xenograft and PDX Models Sales Estimates and Forecasts (2019-2030)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Patient Derived Xenograft and PDX Models Market Competitive Landscape
- 3.1 Global Patient Derived Xenograft and PDX Models Sales by Manufacturers (2019-2024)
- 3.2 Global Patient Derived Xenograft and PDX Models Revenue Market Share by Manufacturers (2019-2024)
- 3.3 Patient Derived Xenograft and PDX Models Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4 Global Patient Derived Xenograft and PDX Models Average Price by Manufacturers (2019-2024)
- 3.5 Manufacturers Patient Derived Xenograft and PDX Models Sales Sites, Area Served, Product Type
- 3.6 Patient Derived Xenograft and PDX Models Market Competitive Situation and Trends
- 3.6.1 Patient Derived Xenograft and PDX Models Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest Patient Derived Xenograft and PDX Models Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 Patient Derived Xenograft and PDX Models Industry Chain Analysis
- 4.1 Patient Derived Xenograft and PDX Models Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Patient Derived Xenograft and PDX Models Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 Industry Policies
- 6 Patient Derived Xenograft and PDX Models Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Patient Derived Xenograft and PDX Models Sales Market Share by Type (2019-2024)
- 6.3 Global Patient Derived Xenograft and PDX Models Market Size Market Share by Type (2019-2024)
- 6.4 Global Patient Derived Xenograft and PDX Models Price by Type (2019-2024)
- 7 Patient Derived Xenograft and PDX Models Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Patient Derived Xenograft and PDX Models Market Sales by Application (2019-2024)
- 7.3 Global Patient Derived Xenograft and PDX Models Market Size (M USD) by Application (2019-2024)
- 7.4 Global Patient Derived Xenograft and PDX Models Sales Growth Rate by Application (2019-2024)
- 8 Patient Derived Xenograft and PDX Models Market Segmentation by Region
- 8.1 Global Patient Derived Xenograft and PDX Models Sales by Region
- 8.1.1 Global Patient Derived Xenograft and PDX Models Sales by Region
- 8.1.2 Global Patient Derived Xenograft and PDX Models Sales Market Share by Region
- 8.2 North America
- 8.2.1 North America Patient Derived Xenograft and PDX Models Sales by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe Patient Derived Xenograft and PDX Models Sales by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Russia
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Patient Derived Xenograft and PDX Models Sales by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America Patient Derived Xenograft and PDX Models Sales by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa Patient Derived Xenograft and PDX Models Sales by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 Crown Bioscience
- 9.1.1 Crown Bioscience Patient Derived Xenograft and PDX Models Basic Information
- 9.1.2 Crown Bioscience Patient Derived Xenograft and PDX Models Product Overview
- 9.1.3 Crown Bioscience Patient Derived Xenograft and PDX Models Product Market Performance
- 9.1.4 Crown Bioscience Business Overview
- 9.1.5 Crown Bioscience Patient Derived Xenograft and PDX Models SWOT Analysis
- 9.1.6 Crown Bioscience Recent Developments
- 9.2 The Jackson Laboratory
- 9.2.1 The Jackson Laboratory Patient Derived Xenograft and PDX Models Basic Information
- 9.2.2 The Jackson Laboratory Patient Derived Xenograft and PDX Models Product Overview
- 9.2.3 The Jackson Laboratory Patient Derived Xenograft and PDX Models Product Market Performance
- 9.2.4 The Jackson Laboratory Business Overview
- 9.2.5 The Jackson Laboratory Patient Derived Xenograft and PDX Models SWOT Analysis
- 9.2.6 The Jackson Laboratory Recent Developments
- 9.3 Champions Oncology
- 9.3.1 Champions Oncology Patient Derived Xenograft and PDX Models Basic Information
- 9.3.2 Champions Oncology Patient Derived Xenograft and PDX Models Product Overview
- 9.3.3 Champions Oncology Patient Derived Xenograft and PDX Models Product Market Performance
- 9.3.4 Champions Oncology Patient Derived Xenograft and PDX Models SWOT Analysis
- 9.3.5 Champions Oncology Business Overview
- 9.3.6 Champions Oncology Recent Developments
- 9.4 Charles River Laboratories
- 9.4.1 Charles River Laboratories Patient Derived Xenograft and PDX Models Basic Information
- 9.4.2 Charles River Laboratories Patient Derived Xenograft and PDX Models Product Overview
- 9.4.3 Charles River Laboratories Patient Derived Xenograft and PDX Models Product Market Performance
- 9.4.4 Charles River Laboratories Business Overview
- 9.4.5 Charles River Laboratories Recent Developments
- 9.5 WuXi Apptec
- 9.5.1 WuXi Apptec Patient Derived Xenograft and PDX Models Basic Information
- 9.5.2 WuXi Apptec Patient Derived Xenograft and PDX Models Product Overview
- 9.5.3 WuXi Apptec Patient Derived Xenograft and PDX Models Product Market Performance
- 9.5.4 WuXi Apptec Business Overview
- 9.5.5 WuXi Apptec Recent Developments
- 9.6 Oncodesign
- 9.6.1 Oncodesign Patient Derived Xenograft and PDX Models Basic Information
- 9.6.2 Oncodesign Patient Derived Xenograft and PDX Models Product Overview
- 9.6.3 Oncodesign Patient Derived Xenograft and PDX Models Product Market Performance
- 9.6.4 Oncodesign Business Overview
- 9.6.5 Oncodesign Recent Developments
- 9.7 Horizon Discovery
- 9.7.1 Horizon Discovery Patient Derived Xenograft and PDX Models Basic Information
- 9.7.2 Horizon Discovery Patient Derived Xenograft and PDX Models Product Overview
- 9.7.3 Horizon Discovery Patient Derived Xenograft and PDX Models Product Market Performance
- 9.7.4 Horizon Discovery Business Overview
- 9.7.5 Horizon Discovery Recent Developments
- 9.8 Pharmatest Services
- 9.8.1 Pharmatest Services Patient Derived Xenograft and PDX Models Basic Information
- 9.8.2 Pharmatest Services Patient Derived Xenograft and PDX Models Product Overview
- 9.8.3 Pharmatest Services Patient Derived Xenograft and PDX Models Product Market Performance
- 9.8.4 Pharmatest Services Business Overview
- 9.8.5 Pharmatest Services Recent Developments
- 9.9 Hera Biolabs
- 9.9.1 Hera Biolabs Patient Derived Xenograft and PDX Models Basic Information
- 9.9.2 Hera Biolabs Patient Derived Xenograft and PDX Models Product Overview
- 9.9.3 Hera Biolabs Patient Derived Xenograft and PDX Models Product Market Performance
- 9.9.4 Hera Biolabs Business Overview
- 9.9.5 Hera Biolabs Recent Developments
- 9.10 EPO Berlin-Buch
- 9.10.1 EPO Berlin-Buch Patient Derived Xenograft and PDX Models Basic Information
- 9.10.2 EPO Berlin-Buch Patient Derived Xenograft and PDX Models Product Overview
- 9.10.3 EPO Berlin-Buch Patient Derived Xenograft and PDX Models Product Market Performance
- 9.10.4 EPO Berlin-Buch Business Overview
- 9.10.5 EPO Berlin-Buch Recent Developments
- 9.11 Xentech
- 9.11.1 Xentech Patient Derived Xenograft and PDX Models Basic Information
- 9.11.2 Xentech Patient Derived Xenograft and PDX Models Product Overview
- 9.11.3 Xentech Patient Derived Xenograft and PDX Models Product Market Performance
- 9.11.4 Xentech Business Overview
- 9.11.5 Xentech Recent Developments
- 9.12 Urolead
- 9.12.1 Urolead Patient Derived Xenograft and PDX Models Basic Information
- 9.12.2 Urolead Patient Derived Xenograft and PDX Models Product Overview
- 9.12.3 Urolead Patient Derived Xenograft and PDX Models Product Market Performance
- 9.12.4 Urolead Business Overview
- 9.12.5 Urolead Recent Developments
- 10 Patient Derived Xenograft and PDX Models Market Forecast by Region
- 10.1 Global Patient Derived Xenograft and PDX Models Market Size Forecast
- 10.2 Global Patient Derived Xenograft and PDX Models Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe Patient Derived Xenograft and PDX Models Market Size Forecast by Country
- 10.2.3 Asia Pacific Patient Derived Xenograft and PDX Models Market Size Forecast by Region
- 10.2.4 South America Patient Derived Xenograft and PDX Models Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Consumption of Patient Derived Xenograft and PDX Models by Country
- 11 Forecast Market by Type and by Application (2025-2030)
- 11.1 Global Patient Derived Xenograft and PDX Models Market Forecast by Type (2025-2030)
- 11.1.1 Global Forecasted Sales of Patient Derived Xenograft and PDX Models by Type (2025-2030)
- 11.1.2 Global Patient Derived Xenograft and PDX Models Market Size Forecast by Type (2025-2030)
- 11.1.3 Global Forecasted Price of Patient Derived Xenograft and PDX Models by Type (2025-2030)
- 11.2 Global Patient Derived Xenograft and PDX Models Market Forecast by Application (2025-2030)
- 11.2.1 Global Patient Derived Xenograft and PDX Models Sales (K Units) Forecast by Application
- 11.2.2 Global Patient Derived Xenograft and PDX Models Market Size (M USD) Forecast by Application (2025-2030)
- 12 Conclusion and Key Findings
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook